Xarelto Lawsuit News: Federal Litigation to Convene Monthly Status Conference June 10th

Share Article

Bernstein Liebhard LLP is representing plaintiffs in federal Xarelto lawsuits, and this conference will likely address issues relevant to those cases.

Free Case Review
Our attorneys are representing plaintiffs in federal Xarelto lawsuits. We anticipate that this conference will address matters relevant to these claims, including the status of discovery and the selection of bellwether trials.

Hundreds of federally-filed Xarelto lawsuits (http://www.xareltolawsuit2015.com/) that have been consolidated in a multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana, continue to move forward. According to court documents, the proceeding is scheduled to convene its next monthly status conference on Wednesday, June 10, 2015 at 9:00 a.m. (In Re: Xarelto Products Liability Litigation, No. 2592)

“Our attorneys are representing plaintiffs in federal Xarelto lawsuits. We anticipate that this conference will address matters relevant to these claims, including the status of discovery and the selection of bellwether trials. We look forward to providing our clients with updates regarding the progress of this litigation,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is actively filing Xarelto lawsuits in U.S. courts, and continues to evaluate claims on behalf of individuals who allegedly suffered life-threatening internal bleeding and other dangerous complications related to its use.

Xarelto Litigation
According to court documents, Xarelto was initially approved by the U.S. Food & Drug Administration in 2011, and is now indicated for the prevention of strokes in people with atrial fibrillation; the treatment of deep vein thrombosis and pulmonary embolism; and the prevention of deep vein thrombosis in patients undergoing hip or knee replacement surgery. Like any anticoagulant, Xarelto is sometimes associated with serious episodes of internal bleeding. However, there is currently no approved antidote to reverse this potentially life-threatening complication. The Xarelto label includes a black box warning that contains information about the increased risk of blood clot formation after premature discontinuation of the medication in the absence of adequate alternative anticoagulation.*

Court records indicate that at least 434 Xarelto lawsuits are pending in the federal multidistrict litigation underway in the Eastern District of Louisiana, all of which were filed on behalf of individuals who allegedly suffered uncontrollable bleeding, strokes, deep vein thrombosis, pulmonary embolism and other complications related to its use. Among other things, plaintiffs accuse the drug’s manufacturers of wrongly marketing Xarelto as a superior alternative for warfarin, a blood thinner that has been in use for decades. They point out that unlike Xarelto, there is an effective antidote for reverse bleeding complications associated with warfarin.

Individuals who allegedly experienced internal bleeding and other complications related to Xarelto may be entitled to compensation for medical bills and other damages incurred as a result of their injuries. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.

*accessdata.fda.gov/drugsatfda_docs/label/2013/022406s004lbl.pdf, FDA, March 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website